glp 1 receptor agonists beyond their pancreatic effects GLP-1 in the Rehabilitation of Patients with Heart Failure: Mechanisms, Clinical Evidence, and Future Perspectives Current Insights, Advantages and Challenges
Description
de Zeeuw, M.C
G., Willett, V
Like most BCBS plans, Anthem typically requires prior authorization and documentation showing that Wegovy is medically necessary
While the therapeutic benefits of GLP-1RAs in diabetes management are well-established, their emerging role in other diseases suggests novel treatment strategies
The market is shaped by high obesity prevalence-over 100 million adults, coupled with reimbursement complexity across Medicare, Medicaid, and commercial plans [1]
They have not undergone the same manufacturing, purity, and efficacy review as brand-name products
